South San FranciscoManufacturingBiotechnologyHealth CareMedicalTherapeuticsresearch
Description
Alexander Hardy, Chief Executive Officer of Genentech, a member of the Roche Group, has decided to leave the company and will step down from his role on November 1st 2023. Hardy first joined Genentech in 2005 and held several senior management positions before assuming the role of CEO in March 2019. Ashley Magargee, Head of US Commercial Portfolio, who has been serving as ad interim CEO during Alexander’s recent sabbatical, will continue in this role until a successor is announced
Company Information
Company
Genentech
Location
1 DNA Way
South San Francisco, California, United States
About
Genentech is passionate about finding solutions for some of the world’s most difficult-to-treat conditions, using cutting-edge science to create and deliver innovative medicines worldwide. With a belief that science is personal, Genentech is dedicated to making a difference in the lives of millions and invites those who share this mission to explore career opportunities at gene.com/careers.
Fundz sees it the moment Genentech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
South San FranciscoManufacturingBiotechnologyHealth CareMedicalTherapeuticsresearch